Pourquoi le calcipotriol irrite-t-il le visage?

Annales de Dermatologie et de Venereologie

Volumn 124, Issue 11, 1997, Pages 771-772

  Guilhou, J J ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0005120758     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Kragballe K, Beck HI, Sogaard H. Improvement of psoriasis by a topical vitamin D, analogue (MC903) in a double-blind study. Brit J Dermatol 1988 ; 119 : 223-30.
2. Kragballe K, Gjertsen BT, De Hopp D, Karlsmark T, Van de Kerkhof PCM, Larkö O et al. Double-blind, right/left comparaison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. The Lancet 1991 ; 337 : 193-6.
3. Ortonne JP. Psoriasis : nouvelle modalité thérapeutique par le calcipotriol plus le dipropionate de betamethasone. Nouv Dermatol 1994 ; 13 : 746-51.
4. Darley CR, Cunliffe WJ, Green CM, Hutchinson PE, Klaber MR, Downes N. Safety and efficacy of calcipotriol ointement (Dovonex) in treating children with psoriasis vulgaris. Brit J Dermatol 1996 ; 135 : 390-3.
5. Kienbaum S, Lehmann P, Ruzicka T. Topical calcipotriol in the treatment of intertriginous psoriasis. Brit J Dermatol 1996 ; 135 : 647-50.
6. Van de Kerkhof PCM, Werfel T, Haustein UF, Luger T, Czarnetzki BM, Niemann R, Plänitz-Stenzel V. Tacalcitol ointement in the treatment of psoriasis vulgaris ; a multicentre, placebo-controlled, double-blind study on efficacy and safety. Brit J Dermatol 1996 ; 135 : 758-65.
7. Molin L, Cutler TP, Helander I, Nyfors B, Downes N. and the calcipotriol Study Group. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Brit J Dermatol 1997 ; 136 : 89-93.
8. Perez A, Chen TC, Turner A, Raab R, Bhawan J, Poche P, Holick MF. Efficacy and safety of topical calcitriol (1,25-dihydroxy vitamin D3) for the treatment of psoriasis. Brit J Dermatol 1996 ; 134 : 238-46.
9. Langner A, Ashton P, Van de Kerkhof PCM, Verlans H. On Behalf of a Multicentre Study Group. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis. Brit J Dermatol 1996 ; 135 : 385-9.
10. Dubertret L, Wallach D, Souteyrand P, Perussel M, Kalis B, Meynadier J et al. Efficacy and safety of calcipotriol (MC903) ointement in psoriasis vulgaris. A randomized double-blind, right/left comparative, vehicle-controlled study. J Am Acad Dermatol 1992 ; 27 : 983-8.
11. Fullerton A, Avnstorp C, Agner T, Dahl JC, Olsen LO, Serup J. Patch test study with calcipotriol ointment in different patient groups including psoriatic patients with and without adverse dermatitis. Acta Derm Venereol (Stockh) 1996 ; 76 : 194-202.